N/A
Manufactured by Chattem, Inc.
12 FDA adverse event reports analyzed
Last updated: 2026-04-15
MENTHOL, CAMPHOR is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Chattem, Inc.. The most commonly reported adverse reactions for MENTHOL, CAMPHOR include DRUG INEFFECTIVE, NO ADVERSE EVENT, APPLICATION SITE VESICLES. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for MENTHOL, CAMPHOR.
Out of 7 classified reports for MENTHOL, CAMPHOR:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 12 FDA FAERS reports that mention MENTHOL, CAMPHOR. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, NO ADVERSE EVENT, APPLICATION SITE VESICLES. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Chattem, Inc. in connection with MENTHOL, CAMPHOR. Always verify the specific product and NDC with your pharmacist.